Clinical Trial Update: Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of RPH-104 to prevent recurrent fever attacks in adults with colchicine-resistant or colchicine-intole…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Familial Mediterranean Fever, FMF | Phase 2 | Status: RECRUITING